Cancer immunotherapy has become a promising method for cancer treatment, bringing
hope to advanced cancer patients. However, immune‐related adverse events caused by …

Cancer immunotherapy and vaccine development have significantly improved the fight
against cancers. Despite these advancements, challenges remain, particularly in the clinical …

Living cell‐mediated nanodelivery system is considered a promising candidate for targeted
antitumor therapy; however, their use is restricted by the adverse interactions between …

In recent years, live-cell-based drug delivery systems have gained considerable attention.
However, shear stress, which accompanies blood flow, may cause cell death and weaken …

Extracellular vesicles (EVs) are promising next‐generation therapeutics and drug delivery
systems due to demonstrated safety and efficacy in preclinical models and early‐stage …

Mesenchymal stem cells (MSCs) play a crucial role in maintaining bone homeostasis and
are extensively explored for cell therapy in various bone‐related diseases. In addition to …

The properties of nanomaterials make them promising and advantageous for use in drug
delivery systems, but challenges arise from the immune system's recognition of exogenous …

Background Hepatocellular carcinoma (HCC) being a complex disease, commonly exhibits
multifaceted presentations, rendering its treatment challenging and necessitating specific …

Immunotherapeutic effect is restricted by the non‐immunogenic tumor phenotype and
immunosuppression behaviors of tumor associated macrophages (TAMs). In this work, a …